Cargando…
Identification of P2RY13 as an immune-related prognostic biomarker in lung adenocarcinoma: A public database-based retrospective study
BACKGROUND: Lung adenocarcinoma (LUAD) is the leading histological subtype of non-small cell lung cancer (NSCLC). METHODS: In the present study, the gene matrixes of LUAD were downloaded from The Cancer Genome Atlas to infer immune and stromal scores with the ‘Estimation of Stromal and Immune cells...
Autores principales: | Lin, Jiang, Wu, Chunlei, Ma, Dehua, Hu, Quanteng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106393/ https://www.ncbi.nlm.nih.gov/pubmed/33996281 http://dx.doi.org/10.7717/peerj.11319 |
Ejemplares similares
-
Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma
por: Wang, Sheng, et al.
Publicado: (2021) -
Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021) -
Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinoma
por: Wu, Chunlei, et al.
Publicado: (2021) -
Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis
por: Li, Zhaodong, et al.
Publicado: (2021) -
Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)